Three Consumer Discretionary Stocks Offer Value Despite Recent Gains

The Motley FoolThe Motley Fool
|||1 min read
Key Takeaway

Three consumer stocks offer value opportunities: Conagra yields 7.6% while implementing AI; Macy's trades at modest multiples despite 75% gains; Signet Jewelers shows 19.7% projected earnings growth.

Three Consumer Discretionary Stocks Offer Value Despite Recent Gains

A trio of consumer-focused companies are trading at valuations that may appeal to value-oriented investors, even as recent share price appreciation has drawn market attention to the sector. Conagra Brands currently yields 7.6% at prevailing prices while the packaged food manufacturer integrates artificial intelligence across its operations. The company's dividend profile presents a notable income component for investors seeking regular distributions.

Macy's department store chain continues to command a modest 12x forward price-to-earnings multiple despite a 75% share price increase over the past six months, reflecting ongoing progress in its operational restructuring program. The valuation multiple remains compressed relative to historical levels even as turnaround initiatives gain traction. Meanwhile, Signet Jewelers trades at 8.5x forward earnings following an 80% annual advance, with consensus forecasts indicating 19.7% earnings growth in the coming period, suggesting potential room for multiple expansion should the company execute on projected results.

Source: The Motley Fool

Back to newsPublished Feb 23

Related Coverage

Investing.com

Macy's Beats Q4 Estimates Yet Again, but Cautious Outlook Tanks Stock

Macy's delivered fourth consecutive earnings beat with $1.67 EPS versus $1.55 expected, but conservative guidance citing macroeconomic headwinds sparked sharp selloff.

M
The Motley Fool

Energy Dividends Face Off: Why ConocoPhillips Edges EOG Resources

ConocoPhillips and EOG Resources both offer dividend yields above 2.5%, but ConocoPhillips' aggressive growth plans and free cash flow projections make it the stronger choice for income investors.

EOGCOP
The Motley Fool

Healthcare's Dividend Gems: Why $ABBV and $BMY Stand Out for Income Investors

$ABBV and $BMY deliver above-average dividend yields and growth, standing out as rare healthcare sector exceptions for patient income investors navigating patent cliffs through innovation.

BMYCELGrABBV
The Motley Fool

BMY's 4.4% Dividend Masks Looming Patent Cliff Risks

Bristol Myers Squibb's attractive 4.4% dividend yield faces headwinds from major patent expirations on blockbuster drugs Eliquis and Opdivo.

BMYCELGr
The Motley Fool

Energy Stocks Surge as Geopolitical Tensions Push Oil Above $100

Oil prices above $100 spark renewed interest in energy stocks. ExxonMobil, Schlumberger, and Enterprise Products Partners emerge as compelling opportunities amid geopolitical tensions.

XOMEPDSLB
The Motley Fool

AbbVie Stock Trades at Bargain Valuation as New Drugs Offset Humira Decline

AbbVie stock down 11% YTD but trades at 14x forward P/E with 0.49 PEG, suggesting undervaluation amid strong new drug momentum and 3.4% dividend yield.

ABBVXLV